CRISPR Therapeutics AG CRSP
Set alert
49.99 USD -1.43 -2.78%
At close
50.02 +0.03 +0.06%
Pre-market · Nov 3, 8:00 AM ET
49.70 Day range 52.12
44.12 52-week range 63.45
- YTD
- -4.67%
- 1 year
- -19.33%
- Open
- 51.90
- Prev close
- 51.42
- Mkt cap
- 4.83B
- Vol
- 1.03M
- Avg vol
- 1.53M
- EPS
- -4.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 49.70
- High
- 52.12
- Forward P/E
- -14.07
- Beta
- 1.90
- Short ratio
- 9.18
- Inst. own
- 79.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 16, 2027
- 50-d avg
- 54.19
- 200-d avg
- 52.88
- 1y target
- 85.63
5D chart
Events in this range
- Nov 2, 2026Earnings: -1.15; estimate -1.04; surprise -10.58%
Signals (138)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:50 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:30 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 2:05 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 1:40 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 1:00 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 19 hours ago |
Newest 20 of 138.
Analyst view
Consensus: buy
Buy
Price target (mean) 85.63 +71.3% upside
Now 49.99
- Target (low)
- 44.00
- Target (mean)
- 85.63
- Target (high)
- 291.00
Ratings (0m) 23 13 buy · 10 hold · 0 sell
- Strong buy4
- Buy9
- Hold10
- Sell0
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 22
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.06 | -1.50 – -0.46 | -1.17 | +9.4% | 16.56M | +1763.3% | 17 |
| Next quarter | -1.16 | -2.02 – -0.51 | -1.37 | +15.2% | 17.43M | +1917.2% | 17 |
| Current year | -4.45 | -5.84 – -3.19 | -6.47 | +31.3% | 40.44M | +1052.1% | 19 |
| Next year | -3.55 | -5.40 – -0.51 | -4.45 | +20.1% | 153.97M | +280.8% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | UBS | Initiated | — | Neutral |
| Aug 31, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 31, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 25, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 4, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 6, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| May 13, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| May 6, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 17, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 17, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Feb 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 13, 2026 | Needham | Maintained | Buy | Buy |
| Jan 30, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Dec 23, 2025 | Needham | Reiterated | Buy | Buy |
| Dec 23, 2025 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Nov 26, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Nov 12, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 11, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 11, 2025 | Baird | Maintained | Neutral | Neutral |
| Nov 10, 2025 | Needham | Maintained | Buy | Buy |
| Oct 17, 2025 | B of A Securities | Maintained | Buy | Buy |
| Oct 10, 2025 | Needham | Reiterated | Buy | Buy |
| Sep 23, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 18, 2025 | JP Morgan | Initiated | — | Overweight |
| Aug 7, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 5, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Aug 5, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |